Hepatitis B and Hepatitis C Articles

Treatment for Hepatitis B: When to Start, What to Use, and When to Stop HCV Vaccine Development Pegylated Interferon Monotherapy for Treatment of Chronic Hepatitis B ImQuest Identifies First Non-nucleoside Inhibitors of Hepatitis B Virus Studies Shed More Light on Acute Hepatitis C among HIV Positive Men in the U.S. and Europe HCV Reinfection and Superinfection Are Common among Injection Drug Users Tenofovir (Viread) during Pregnancy: Findings from the Antiretroviral Pregnancy Registry Many Asian-American Primary Care Providers Do Not Screen their Asian-American Patients Who Are at Risk for Chronic Hepatitis B Tenofovir (Viread) during Pregnancy: Findings from the Antiretroviral Pregnancy Registry Chronic Hepatitis B Patients May Need to Begin Liver Cancer Screening at a Younger Age than Currently Recommended

Library of Slides and Posters

Safety and antiviral activity of TMC435 (TMC435350) in treatment-naïve genotype 1 HCV-infected patients Study TMC435-C201 Tenofovir Disoproxil Fumarate (TDF) versus Adefovir Dipivoxil (ADV) in Asians with HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B Participating in Studies 102 and 103 Two Year Tenofovir Disoproxil Fumarate (TDF) Treatment and Adefovir Dipivoxil (ADV) Switch Data in HBeAg-Negative Patients with Chronic Hepatitis B (Study 102) Variables Impacting Treatment and Prognosis in Young Patients (under Age 40) who Develop Hepatitis B Virus-Associated Hepatocellular Carcinoma; Implications for Management of an Unscreened Population Two Year Tenofovir Disoproxil Fumarate (TDF) Treatment and Adefovir Dipivoxil (ADV) Switch Data in HBeAg-Positive Patients With Chronic Hepatitis B (Study 103)

 HIV and Hepatitis.com Coverage of the 13th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD 2009)